EBITDA Summary of Cellcom Israel Ltd.

Cellcom Israel Ltd.'s latest annual EBITDA in 2023 was 1.21 Billion ILS , up 5.51% from previous year.
Cellcom Israel Ltd.'s latest quarterly EBITDA in 2024 Q2 was 288 Million ILS , up 24.0% from previous quarter.
Cellcom Israel Ltd. reported an annual EBITDA of 1.17 Billion ILS in 2022, up 7.47% from previous year.
Cellcom Israel Ltd. reported an annual EBITDA of 1.1 Billion ILS in 2021, up 22.98% from previous year.
Cellcom Israel Ltd. reported a quarterly EBITDA of 277 Million ILS for 2024 Q1, down -3.85% from previous quarter.
Cellcom Israel Ltd. reported a quarterly EBITDA of 336 Million ILS for 2023 Q3, up 20.0% from previous quarter.

Annual EBITDA Chart of Cellcom Israel Ltd. (2023 - 2001)

Historical Annual EBITDA of Cellcom Israel Ltd. (2023 - 2001)

Year	EBITDA	EBITDA Growth
2023	1.21 Billion ILS	5.51%
2022	1.17 Billion ILS	7.47%
2021	1.1 Billion ILS	22.98%
2020	883 Million ILS	-2.73%
2019	935 Million ILS	36.26%
2018	684 Million ILS	-23.61%
2017	841 Million ILS	1.15%
2016	867 Million ILS	-4.6%
2015	896 Million ILS	-32.02%
2014	1.31 Billion ILS	-2.89%
2013	1.32 Billion ILS	-24.14%
2012	1.9 Billion ILS	-19.9%
2011	2.15 Billion ILS	811.53%
2010	2.66 Billion ILS	-90.66%
2009	2.67 Billion ILS	11.65%
2008	2.39 Billion ILS	11.72%
2007	2.12 Billion ILS	15.14%
2006	1.85 Billion ILS	5.13%
2005	1.75 Billion ILS	-6.95%
2004	1.9 Billion ILS	-63.81%
2003	5.25 Billion ILS	651.36%
2002	695 Million ILS	-85.89%
2001	4.96 Billion ILS	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	288 Million ILS	24.0%
2024 Q1	277 Million ILS	-3.85%
2023 Q3	336 Million ILS	20.0%
2023 FY	- ILS	5.51%
2023 Q4	286 Million ILS	-14.88%
2023 Q2	280 Million ILS	-10.54%
2023 Q1	313 Million ILS	4.68%
2022 Q2	312 Million ILS	9.86%
2022 Q4	299 Million ILS	-4.78%
2022 Q3	314 Million ILS	0.64%
2022 FY	- ILS	7.47%
2022 Q1	284 Million ILS	1.07%
2021 Q1	280 Million ILS	76.1%
2021 Q3	277 Million ILS	6.13%
2021 Q4	281 Million ILS	1.44%
2021 FY	- ILS	22.98%
2021 Q2	261 Million ILS	-6.79%
2020 Q3	232 Million ILS	2.65%
2020 FY	- ILS	-2.73%
2020 Q4	159 Million ILS	-31.47%
2020 Q1	242 Million ILS	28.04%
2020 Q2	226 Million ILS	-6.61%
2019 Q2	243 Million ILS	0.83%
2019 FY	- ILS	36.26%
2019 Q1	241 Million ILS	66.21%
2019 Q3	271 Million ILS	11.52%
2019 Q4	189 Million ILS	-30.26%
2018 FY	- ILS	-23.61%
2018 Q2	151 Million ILS	-20.11%
2018 Q3	198 Million ILS	31.13%
2018 Q4	145 Million ILS	-26.77%
2018 Q1	189 Million ILS	2.16%
2017 Q1	216 Million ILS	33.33%
2017 Q3	238 Million ILS	-5.56%
2017 Q2	252 Million ILS	16.67%
2017 FY	- ILS	1.15%
2017 Q4	185 Million ILS	-22.27%
2016 Q2	252 Million ILS	0.8%
2016 Q1	250 Million ILS	31.58%
2016 Q3	216 Million ILS	-14.29%
2016 Q4	162 Million ILS	-25.0%
2016 FY	- ILS	-4.6%
2015 Q2	245 Million ILS	9.87%
2015 Q4	190 Million ILS	-25.49%
2015 Q1	223 Million ILS	-9.35%
2015 FY	- ILS	-32.02%
2015 Q3	255 Million ILS	4.08%
2014 Q1	376 Million ILS	35.74%
2014 FY	- ILS	-2.89%
2014 Q4	246 Million ILS	-34.4%
2014 Q3	375 Million ILS	9.65%
2014 Q2	342 Million ILS	-9.04%
2013 Q2	382 Million ILS	8.83%
2013 Q4	277 Million ILS	-27.11%
2013 Q3	380 Million ILS	-0.52%
2013 FY	- ILS	-24.14%
2013 Q1	351 Million ILS	12.14%
2012 Q1	516 Million ILS	13.91%
2012 Q2	520 Million ILS	0.78%
2012 Q3	495 Million ILS	-4.81%
2012 Q4	313 Million ILS	-36.77%
2012 FY	- ILS	-19.9%
2011 FY	- ILS	811.53%
2011 Q2	610 Million ILS	-7.29%
2011 Q1	658 Million ILS	-1.2%
2011 Q3	567 Million ILS	-7.05%
2011 Q4	453 Million ILS	-20.11%
2010 Q3	738 Million ILS	1.37%
2010 Q4	666 Million ILS	-9.76%
2010 Q2	728 Million ILS	10.14%
2010 FY	- ILS	-90.66%
2010 Q1	661 Million ILS	6.96%
2009 Q4	618 Million ILS	-9.65%
2009 Q1	669 Million ILS	26.99%
2009 FY	- ILS	11.65%
2009 Q2	708 Million ILS	5.83%
2009 Q3	684 Million ILS	-3.39%
2008 Q4	526.79 Million ILS	-18.37%
2008 Q2	621.06 Million ILS	5.37%
2008 Q3	645.32 Million ILS	3.91%
2008 FY	- ILS	11.72%
2008 Q1	589.42 Million ILS	21.14%
2007 Q1	348.77 Million ILS	-18.79%
2007 Q4	486.57 Million ILS	-13.27%
2007 Q3	561.02 Million ILS	62.97%
2007 Q2	344.25 Million ILS	-1.3%
2007 FY	- ILS	15.14%
2006 FY	- ILS	5.13%
2006 Q2	1.44 Billion ILS	-5.36%
2006 Q3	258.12 Million ILS	-82.09%
2006 Q1	1.52 Billion ILS	148.16%
2006 Q4	429.44 Million ILS	66.38%
2005 Q2	1.28 Billion ILS	0.27%
2005 Q1	1.27 Billion ILS	139.36%
2005 Q3	1.27 Billion ILS	-0.31%
2005 Q4	-3.16 Billion ILS	-347.43%
2005 FY	- ILS	-6.95%
2004 Q1	1.39 Billion ILS	1193.52%
2004 Q3	1.39 Billion ILS	-0.07%
2004 FY	- ILS	-63.81%
2004 Q4	-3.24 Billion ILS	-332.38%
2004 Q2	1.39 Billion ILS	0.17%
2003 FY	- ILS	651.36%
2003 Q1	107.93 Million ILS	-36.97%
2003 Q2	107.93 Million ILS	0.0%
2003 Q3	107.93 Million ILS	0.0%
2003 Q4	107.93 Million ILS	0.0%
2002 Q4	171.25 Million ILS	0.0%
2002 Q2	171.25 Million ILS	0.0%
2002 FY	- ILS	-85.89%
2002 Q1	171.25 Million ILS	19.13%
2002 Q3	171.25 Million ILS	0.0%
2001 Q3	143.75 Million ILS	0.0%
2001 Q4	143.75 Million ILS	0.0%
2001 Q1	143.75 Million ILS	0.0%
2001 Q2	143.75 Million ILS	0.0%
2001 FY	- ILS	0.0%

Peer EBITDA Comparison of Cellcom Israel Ltd.

Name	EBITDA	EBITDA Difference

Global Stocks Search

Cellcom Israel Ltd. (CEL.TA)

EBITDA Summary of Cellcom Israel Ltd.

Annual EBITDA Chart of Cellcom Israel Ltd. (2023 - 2001)

Historical Annual EBITDA of Cellcom Israel Ltd. (2023 - 2001)

Peer EBITDA Comparison of Cellcom Israel Ltd.